Blood Transfusion Diagnostics Market

• Instruments
• Kits & Reagents

• Blood Grouping
• Disease Screening
  • Serological Disease Screening
  • Molecular Disease Screening

• Hospitals
• Blood Banks
• Diagnostic Laboratories
• Plasma Fractionation Companies
• Others

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

• Grifols S.A.
• Immucor, Inc.
• Ortho Clinical Diagnostics
• Abbott
• Bio-Rad Laboratories, Inc.
• F. Hoffman-La Roche Ltd.
• QUOTIENT LIMITED
• BAG Healthcare GmBH
• DiaSorin S.p.A.
• Hologic, Inc.

Table 01: Global Market Revenue (USD Million) Forecast, by Product Type, 2025 to 2035

Table 02: Global Market Revenue (USD Million) Forecast, by Application, 2025 to 2035

Table 03: Global Market Revenue (USD Million) Forecast, by Disease Screening, 2025 to 2035

Table 04: Global Market Revenue (USD Million) Forecast, by End-user, 2025 to 2035

Table 05: Global Market Revenue (USD Million) Forecast, by Region, 2025 to 2035

Table 06: North America Market Revenue (USD Million) Forecast, by Country, 2025 to 2035

Table 07: North America Market Revenue (USD Million) Forecast, by Product Type, 2025 to 2035

Table 08: North America Market Revenue (USD Million) Forecast, by Application, 2025 to 2035

Table 09: North America Market Revenue (USD Million) Forecast, by Disease Screening, 2025 to 2035

Table 10: North America Market Revenue (USD Million) Forecast, by End User, 2025 to 2035

Table 11: Europe Market Revenue (USD Million) Forecast, by Country/Sub-region, 2025 to 2035

Table 12: Europe Market Revenue (USD Million) Forecast, by Product Type, 2025 to 2035

Table 13: Europe Market Revenue (USD Million) Forecast, by Application, 2025 to 2035

Table 14: Europe Market Revenue (USD Million) Forecast, by Disease Screening, 2025 to 2035

Table 15: Europe Market Revenue (USD Million) Forecast, by End-user, 2025 to 2035

Table 16: Asia Pacific Market Revenue (USD Million) Forecast, by Country/Sub-region, 2025 to 2035

Table 17: Asia Pacific Market Revenue (USD Million) Forecast, by Product Type, 2025 to 2035

Table 18: Asia Pacific Market Revenue (USD Million) Forecast, by Application, 2025 to 2035

Table 19: Asia Pacific Market Revenue (USD Million) Forecast, by Disease Screening, 2025 to 2035

Table 20: Asia Pacific Market Revenue (USD Million) Forecast, by End User, 2025 to 2035

Table 21: Latin America Market Revenue (USD Million) Forecast, by Country/Sub-region, 2025 to 2035

Table 22: Latin America Market Revenue (USD Million) Forecast, by Product Type, 2025 to 2035

Table 23: Latin America Market Revenue (USD Million) Forecast, by Application, 2025 to 2035

Table 24: Latin America Market Revenue (USD Million) Forecast, by Disease Screening, 2025 to 2035

Table 25: Latin America Market Revenue (USD Million) Forecast, by End-user, 2025 to 2035

Table 26: Middle East & Africa Market Revenue (USD Million) Forecast, by Country/Sub-region, 2025 to 2035

Table 27: Middle East & Africa Market Revenue (USD Million) Forecast, by Product Type, 2025 to 2035

Table 28: Middle East & Africa Market Revenue (USD Million) Forecast, by Application, 2025 to 2035

Table 29: Middle East & Africa Market Revenue (USD Million) Forecast, by Disease Screening, 2025 to 2035

Table 30: Middle East & Africa Market Revenue (USD Million) Forecast, by End-user, 2025 to 2035

Figure 01: Global Market Size (USD Million) Forecast, 2025 to 2035

Figure 02: Global Market Value Share, by Region (2018)

Figure 04: Global Market Value Share, by Application (2018)

Figure 03: Global Market Value Share, by Product Type (2018)

Figure 05: Global Market Value Share, by End-user (2018)

Figure 06: Global Market Value Share, by Product Type, 2025 and 2035

Figure 07: Global Market Revenue (USD Million) and Y-o-Y Growth (%) Forecast, by Instruments, 2025 to 2035

Figure 08: Global Market Revenue (USD Million) and Y-o-Y Growth (%) Forecast, by Kits & Reagents,

Figure 09: Global Market Attractiveness, by Product Type, 2025 to 2035

Figure 10: Global Market Value Share, by Application, 2025 and 2035

Figure 11: Global Market Revenue (USD Million) and Y-o-Y Growth (%) Forecast, by Blood Grouping, 2025 to 2035

Figure 12: Global Market Revenue (USD Million) and Y-o-Y Growth (%) Forecast, by Disease Screening,

Figure 13: Global Market Attractiveness, by Application, 2025 to 2035

Figure 14: Global Market Value Share, by End-user, 2025 and 2035

Figure 15: Global Market Revenue (USD Million) and Y-o-Y Growth (%) Forecast, by Hospitals, 2025 to 2035

Figure 16: Global Market Revenue (USD Million) and Y-o-Y Growth (%) Forecast, by Blood Banks,

Figure 17: Global Market Revenue (USD Million) and Y-o-Y Growth (%) Forecast, by Diagnostic Laboratories, 2025 to 2035

Figure 18: Global Market Revenue (USD Million) and Y-o-Y Growth (%) Forecast, by Plasma Fractionation Companies, 2025 to 2035

Figure 19: Global Market Revenue (USD Million) and Y-o-Y Growth (%) Forecast, by Others, 2025 to 2035

Figure 20: Global Market Attractiveness, by End-user, 2025 to 2035

Figure 21: Global Market Value Share, by Region, 2025 and 2035

Figure 22: Global Market Attractiveness, by Region, 2025 to 2035

Figure 23: North America Market Value Share, by Country, 2025 and 2035

Figure 24: North America Market Attractiveness, by Country, 2025 to 2035

Figure 25: North America Market Value Share, by Product Type, 2025 and 2035

Figure 26: North America Market Attractiveness, by Product Type, 2025 to 2035

Figure 27: North America Market Value Share, by Application, 2025 and 2035

Figure 28: North America Market Attractiveness, by Application, 2025 to 2035

Figure 29: North America Market Value Share, by End-user, 2025 and 2035

Figure 30: North America Market Attractiveness, by End-user, 2025 to 2035

Figure 31: Europe Market Value Share, by Country/Sub-region, 2025 and 2035

Figure 32: Europe Market Attractiveness, by Country/Sub-region, 2025 to 2035

Figure 33: Europe Market Value Share, by Product Type, 2025 and 2035

Figure 34: Europe Market Attractiveness, by Product Type, 2025 to 2035

Figure 35: Europe Market Value Share, by Application, 2025 and 2035

Figure 36: Europe Market Attractiveness, by Application, 2025 to 2035

Figure 37: Europe Market Value Share, by End-user, 2025 and 2035

Figure 38: Europe Market Attractiveness, by End-user, 2025 to 2035

Figure 39: Asia Pacific Market Value Share, by Country/Sub-region, 2025 and 2035

Figure 40: Asia Pacific Market Attractiveness, by Country/Sub-region, 2025 to 2035

Figure 41: Asia Pacific Market Value Share, by Product Type, 2025 and 2035

Figure 42: Asia Pacific Market Attractiveness, by Product Type, 2025 to 2035

Figure 43: Asia Pacific Market Value Share, by Application, 2025 and 2035

Figure 44: Asia Pacific Market Attractiveness, by Application, 2025 to 2035

Figure 45: Asia Pacific Market Value Share, by End-user, 2025 and 2035

Figure 46: Asia Pacific Market Attractiveness, by End-user, 2025 to 2035

Figure 47: Latin America Market Value Share, by Country/Sub-region, 2020 and 2025

Figure 48: Latin America Market Attractiveness, by Country/Sub-Region, 2025 to 2035

Figure 49: Latin America Market Value Share, by Product Type, 2025 and 2035

Figure 50: Latin America Market Attractiveness, by Product Type, 2025 to 2035

Figure 51: Latin America Market Value Share, by Application, 2025 and 2035

Figure 52: Latin America Market Attractiveness, by Application, 2025 to 2035

Figure 53: Latin America Market Value Share, by End-user, 2025 and 2035

Figure 54: Latin America Market Attractiveness, by End-user, 2025 to 2035

Figure 55: Middle East & Africa Market Value Share, by Country/Sub-Region, 2025 and 2035

Figure 56: Middle East & Africa Market Attractiveness, by Country/Sub-region, 2025 to 2035

Figure 57: Middle East & Africa Market Value Share, by Product Type, 2025 and 2035

Figure 58: Middle East & Africa Market Attractiveness, by Product Type, 2025 to 2035

Figure 59: Middle East & Africa Market Value Share, by Application, 2025 and 2035

Figure 60: Middle East & Africa Market Attractiveness, by Application, 2025 to 2035

Figure 61: Middle East & Africa Market Value Share, by End-user, 2025 and 2035

Figure 62: Middle East & Africa Market Attractiveness, by End-user, 2025 to 2035

Figure 63: Global Market Share (%) & Market Share Range (%), by Company, 2020 (Estimated)

Figure 64: Grifols S.A. Breakdown of Net Sales, by Business Segment, 2020

Figure 65: Grifols S.A. Revenue (USD Million) and Y-o-Y Growth (%), 2017 to 2021

Figure 66: DiaSorin S.p.A. Breakdown of Net Sales, by Region, 2020

Figure 67: DiaSorin S.p.A. Revenue (USD Million) and Y-o-Y Growth (%), 2017 to 2021

Figure 68: Immucor, Inc., Breakdown of Net Sales, by Product Group, 2021

Figure 69: Immucor, Inc., Revenue (USD Million) and Y-o-Y Growth (%), 2017 to 2021

Figure 70: Abbott Breakdown of Revenue (USD Million), by Region, 2021

Figure 71: Abbott Revenue (USD Bilion) and Y-o-Y Growth (%), 2017 to 2021

Figure 72: Bio-Rad Laboratories, Inc., Breakdown of Net Sales, by Region, 2021

Figure 73: Bio-Rad Laboratories, Inc., Revenue (USD Billion) and Y-o-Y Growth (%), 2017 to 2021

Figure 74: Hologic, Inc., Breakdown of Net Sales, by Region, 2021

Figure 75: Hologic, Inc., Revenue (USD Million) and Y-o-Y Growth (%), 2017 to 2021

Figure 76: QUOTIENT LIMITED, Breakdown of Net Sales, by Product Group, 2021

Figure 77: QUOTIENT LIMITED, Revenue (USD Million) and Y-o-Y Growth (%), 2017 to 2021

Figure 78: F. Hoffmann-La Roche Ltd., Breakdown of Net Sales, by Business Segment, 2021

Figure 79: F. Hoffmann-La Roche Ltd., Revenue (USD Million) and Y-o-Y Growth (%), 2017 to 2021